# Unifi Inc: financial statements, quarterly

UFI · NYSE · CIK 100726 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jul 3

Pages: [Overview](/companies/ufi.md) · [Financials](/companies/ufi/financials.md) · [Filings](/companies/ufi/filings.md) · [Insiders](/companies/ufi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ufi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-10-01) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q4 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [139](/filings/0000950170-25-111331.md) | [137](/filings/0000950170-25-111331.md) | [149](/filings/0000950170-25-111331.md) | [157](/filings/0000950170-25-111331.md) | [147](/filings/0000100726-26-000012.md) | [139](/filings/0000100726-26-000012.md) | [147](/filings/0000100726-26-000012.md) | [139](/filings/0000100726-26-000012.md) | [136](/filings/0000100726-26-000012.md) | [121](/filings/0000100726-26-000012.md) | [130](/filings/0000100726-26-000012.md) | [144](/filings/0000100726-26-000012.md) |
| Cost of revenue | $m | [139](/filings/0000950170-24-121858.md) | [135](/filings/0000950170-25-015046.md) | [144](/filings/0000950170-25-065060.md) | [147 d](/filings/0000100726-26-000012.md) | [138](/filings/0001193125-25-266847.md) | [138](/filings/0001193125-26-037524.md) | [147](/filings/0000100726-26-000004.md) | [140 d](/filings/0000100726-26-000012.md) | [132](/filings/0001193125-25-266847.md) | [118](/filings/0001193125-26-037524.md) | [121](/filings/0000100726-26-000004.md) | [130 d](/filings/0000100726-26-000012.md) |
| Gross profit | $m | [(0.6)](/filings/0000950170-25-111331.md) | [1.6](/filings/0000950170-25-111331.md) | [4.8](/filings/0000950170-25-111331.md) | [10.8](/filings/0000950170-25-111331.md) | [9.5](/filings/0000100726-26-000012.md) | [0.5](/filings/0000100726-26-000012.md) | [(0.4)](/filings/0000100726-26-000012.md) | [(1.1)](/filings/0000100726-26-000012.md) | [3.4](/filings/0000100726-26-000012.md) | [3.6](/filings/0000100726-26-000012.md) | [9.1](/filings/0000100726-26-000012.md) | [14.3](/filings/0000100726-26-000012.md) |
| Selling, general and administrative | $m | [11.6](/filings/0000950170-24-121858.md) | [12.4](/filings/0000950170-25-015046.md) | [11.4](/filings/0000950170-25-065060.md) | [11.2 d](/filings/0000100726-26-000012.md) | [11.8](/filings/0001193125-25-266847.md) | [12.9](/filings/0001193125-26-037524.md) | [12.3](/filings/0000100726-26-000004.md) | [11.9 d](/filings/0000100726-26-000012.md) | [11.9](/filings/0001193125-25-266847.md) | [9.7](/filings/0001193125-26-037524.md) | [11.2](/filings/0000100726-26-000004.md) | [11.8 d](/filings/0000100726-26-000012.md) |
| Operating income | $m | [(12.0)](/filings/0000950170-24-121858.md) | [(17.6)](/filings/0000950170-25-015046.md) | [(6.9)](/filings/0000950170-25-065060.md) | [(0.8) d](/filings/0000100726-26-000012.md) | [(3.2)](/filings/0001193125-25-266847.md) | [(7.6)](/filings/0001193125-26-037524.md) | [(13.9)](/filings/0000100726-26-000004.md) | [15.1 d](/filings/0000100726-26-000012.md) | [(9.6)](/filings/0001193125-25-266847.md) | [(7.3)](/filings/0001193125-26-037524.md) | [(0.1)](/filings/0000100726-26-000004.md) | [2.4 d](/filings/0000100726-26-000012.md) |
| Interest expense | $m | [2.5](/filings/0000950170-24-121858.md) | [2.6](/filings/0000950170-25-015046.md) | [2.4](/filings/0000950170-25-065060.md) | [2.4 d](/filings/0000100726-26-000012.md) | [2.5](/filings/0001193125-25-266847.md) | [2.4](/filings/0001193125-26-037524.md) | [2.4](/filings/0000100726-26-000004.md) | [2.2 d](/filings/0000100726-26-000012.md) | [2.0](/filings/0001193125-25-266847.md) | [1.8](/filings/0001193125-26-037524.md) | [1.6](/filings/0000100726-26-000004.md) | [1.4 d](/filings/0000100726-26-000012.md) |
| Income tax | $m | [(0.5)](/filings/0000950170-24-121858.md) | [0.4](/filings/0000950170-25-015046.md) | [0.8](/filings/0000950170-25-065060.md) | [1.2 d](/filings/0000100726-26-000012.md) | [2.2](/filings/0001193125-25-266847.md) | [1.3](/filings/0001193125-26-037524.md) | [0.5](/filings/0000100726-26-000004.md) | [(2.3) d](/filings/0000100726-26-000012.md) | [0.2](/filings/0001193125-25-266847.md) | [1.0](/filings/0001193125-26-037524.md) | [0.8](/filings/0000100726-26-000004.md) | [2.6 d](/filings/0000100726-26-000012.md) |
| Net income | $m | [(13.3)](/filings/0000950170-25-111331.md) | [(19.8)](/filings/0000950170-25-111331.md) | [(10.3)](/filings/0000950170-25-111331.md) | [(4.0)](/filings/0000950170-25-111331.md) | [(7.6)](/filings/0000100726-26-000012.md) | [(11.4)](/filings/0000100726-26-000012.md) | [(16.8)](/filings/0000100726-26-000012.md) | [15.5](/filings/0000100726-26-000012.md) | [(11.4)](/filings/0000100726-26-000012.md) | [(9.7)](/filings/0000100726-26-000012.md) | [(2.3)](/filings/0000100726-26-000012.md) | [(1.2)](/filings/0000100726-26-000012.md) |
| Diluted EPS | $ per share | [(0.73)](/filings/0000950170-25-111331.md) | [(1.10)](/filings/0000950170-25-111331.md) | [(0.57)](/filings/0000950170-25-111331.md) | [(0.22)](/filings/0000950170-25-111331.md) | [(0.42)](/filings/0000100726-26-000012.md) | [(0.62)](/filings/0000100726-26-000012.md) | [(0.92)](/filings/0000100726-26-000012.md) | [0.82](/filings/0000100726-26-000012.md) | [(0.62)](/filings/0000100726-26-000012.md) | [(0.53)](/filings/0000100726-26-000012.md) | [(0.12)](/filings/0000100726-26-000012.md) | [(0.06)](/filings/0000100726-26-000012.md) |
| Basic EPS | $ per share | [(0.73)](/filings/0000950170-25-111331.md) | [(1.10)](/filings/0000950170-25-111331.md) | [(0.57)](/filings/0000950170-25-111331.md) | [(0.22)](/filings/0000950170-25-111331.md) | [(0.42)](/filings/0000100726-26-000012.md) | [(0.62)](/filings/0000100726-26-000012.md) | [(0.92)](/filings/0000100726-26-000012.md) | [0.84](/filings/0000100726-26-000012.md) | [(0.62)](/filings/0000100726-26-000012.md) | [(0.53)](/filings/0000100726-26-000012.md) | [(0.12)](/filings/0000100726-26-000012.md) | [(0.06)](/filings/0000100726-26-000012.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-10-01) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [51.5](/filings/0000950170-23-060698.md) | [36.0](/filings/0000950170-24-012169.md) | [27.7](/filings/0000950170-24-056853.md) | [26.8](/filings/0000950170-25-111331.md) | [13.7](/filings/0000950170-24-121858.md) | [18.7](/filings/0000950170-25-015046.md) | [16.3](/filings/0000950170-25-065060.md) | [22.7](/filings/0000100726-26-000012.md) | [20.6](/filings/0001193125-25-266847.md) | [30.2](/filings/0001193125-26-037524.md) | [26.6](/filings/0000100726-26-000004.md) | [25.1](/filings/0000100726-26-000012.md) |
| Current assets | $m | [277](/filings/0000950170-23-060698.md) | [256](/filings/0000950170-24-012169.md) | [252](/filings/0000950170-24-056853.md) | [249](/filings/0000950170-25-111331.md) | [251](/filings/0000950170-24-121858.md) | [231](/filings/0000950170-25-015046.md) | [246](/filings/0000950170-25-065060.md) | [236](/filings/0000100726-26-000012.md) | [233](/filings/0001193125-25-266847.md) | [199](/filings/0001193125-26-037524.md) | [212](/filings/0000100726-26-000004.md) | [211](/filings/0000100726-26-000012.md) |
| Total assets | $m | [516](/filings/0000950170-23-060698.md) | [492](/filings/0000950170-24-012169.md) | [483](/filings/0000950170-24-056853.md) | [469](/filings/0000950170-25-111331.md) | [467](/filings/0000950170-24-121858.md) | [440](/filings/0000950170-25-015046.md) | [447](/filings/0000950170-25-065060.md) | [427](/filings/0000100726-26-000012.md) | [425](/filings/0001193125-25-266847.md) | [383](/filings/0001193125-26-037524.md) | [392](/filings/0000100726-26-000004.md) | [386](/filings/0000100726-26-000012.md) |
| Current liabilities | $m | [68.7](/filings/0000950170-23-060698.md) | [68.5](/filings/0000950170-24-012169.md) | [77.7](/filings/0000950170-24-056853.md) | [76.6](/filings/0000950170-25-111331.md) | [76.3](/filings/0000950170-24-121858.md) | [67.2](/filings/0000950170-25-015046.md) | [78.6](/filings/0000950170-25-065060.md) | [70.9](/filings/0000100726-26-000012.md) | [65.0](/filings/0001193125-25-266847.md) | [49.9](/filings/0001193125-26-037524.md) | [68.1](/filings/0000100726-26-000004.md) | [63.6](/filings/0000100726-26-000012.md) |
| Total liabilities | $m | [211](/filings/0000950170-23-060698.md) | [201](/filings/0000950170-24-012169.md) | [205](/filings/0000950170-24-056853.md) | [206](/filings/0000950170-25-111331.md) | [207](/filings/0000950170-24-121858.md) | [202](/filings/0000950170-25-015046.md) | [218](/filings/0000950170-25-065060.md) | [177](/filings/0000100726-26-000012.md) | [184](/filings/0001193125-25-266847.md) | [153](/filings/0001193125-26-037524.md) | [161](/filings/0000100726-26-000004.md) | [154](/filings/0000100726-26-000012.md) |
| Long-term debt | $m | not reported | not reported | not reported | [0.0](/filings/0000950170-24-100146.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [305](/filings/0000950170-25-015046.md) | [291](/filings/0000950170-25-065060.md) | [278](/filings/0000950170-25-065060.md) | [263](/filings/0000100726-26-000012.md) | [260](/filings/0001193125-26-037524.md) | [237](/filings/0000100726-26-000004.md) | [228](/filings/0000100726-26-000004.md) | [249](/filings/0000100726-26-000012.md) | [241](/filings/0001193125-26-037524.md) | [230](/filings/0000100726-26-000004.md) | [232](/filings/0000100726-26-000004.md) | [232](/filings/0000100726-26-000012.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-10-01) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q4 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.1](/filings/0000950170-24-121858.md) | [(4.6) d](/filings/0000950170-25-015046.md) | [(1.4) d](/filings/0000950170-25-065060.md) | [0.9 d](/filings/0000100726-26-000012.md) | [(12.8)](/filings/0001193125-25-266847.md) | [(2.2) d](/filings/0001193125-26-037524.md) | [(5.0) d](/filings/0000100726-26-000004.md) | [(1.3) d](/filings/0000100726-26-000012.md) | [(8.9)](/filings/0001193125-25-266847.md) | [25.3 d](/filings/0001193125-26-037524.md) | [8.0 d](/filings/0000100726-26-000004.md) | [2.1 d](/filings/0000100726-26-000012.md) |
| Capital expenditure | $m | [2.9](/filings/0000950170-24-121858.md) | [3.0 d](/filings/0000950170-25-015046.md) | [2.6 d](/filings/0000950170-25-065060.md) | [2.6 d](/filings/0000100726-26-000012.md) | [2.0](/filings/0001193125-25-266847.md) | [2.9 d](/filings/0001193125-26-037524.md) | [3.0 d](/filings/0000100726-26-000004.md) | [2.6 d](/filings/0000100726-26-000012.md) | [2.0](/filings/0001193125-25-266847.md) | [1.1 d](/filings/0001193125-26-037524.md) | [0.8 d](/filings/0000100726-26-000004.md) | [1.1 d](/filings/0000100726-26-000012.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-02) | Q2 FY2023 (2023-01-01) | Q3 FY2023 (2023-04-02) | Q1 FY2024 (2023-10-01) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.0](/filings/0000950170-23-060698.md) | [18.0](/filings/0000950170-24-012169.md) | [18.1](/filings/0000950170-24-056853.md) | [18.1](/filings/0000950170-24-121858.md) | [18.1](/filings/0000950170-25-015046.md) | [18.2](/filings/0000950170-25-065060.md) | [18.3](/filings/0001193125-25-266847.md) | [18.3](/filings/0001193125-26-037524.md) | [18.4](/filings/0000100726-26-000004.md) | [18.4](/filings/0001193125-25-266847.md) | [18.4](/filings/0001193125-26-037524.md) | [18.6](/filings/0000100726-26-000004.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,588,837 at 2026-08-20, from the cover of the [10-K filed 2026-08-26](/filings/0000100726-26-000012.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.